Eli Lilly and Company logo

Eli Lilly and Company (LLY)

Market Closed
17 Jul, 15:30
XETRA XETRA
1,036. 60
+2.2
+0.2127%
- Market Cap
104.2 P/E Ratio
0.05% Div Yield
916 Volume
6.64 Eps
1,034.4
Previous Close
Add Transaction
Day Range
1,008.8 1,037
Year Range
535.8 1,090.8
Want to track LLY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Eli Lilly and Company logo
LLY Eli Lilly and Company
30 Apr 2026
7.25
-
Eli Lilly and Company logo
LLY Eli Lilly and Company
5 Feb 2026
7.17
-
Eli Lilly and Company logo
LLY Eli Lilly and Company
30 Oct 2025
5.92
5.32
Eli Lilly and Company logo
LLY Eli Lilly and Company
7 Aug 2025
5.59
5.55
Eli Lilly and Company logo
LLY Eli Lilly and Company
28 Apr 2025
-
-
Eli Lilly and Company logo
LLY Eli Lilly and Company
4 Feb 2025
-
4.58
Eli Lilly and Company logo
LLY Eli Lilly and Company
30 Oct 2024
-
0.98
Eli Lilly and Company logo
LLY Eli Lilly and Company
8 Aug 2024
-
3.05
Eli Lilly and Company logo
LLY Eli Lilly and Company
30 Apr 2024
-
2.29
Eli Lilly and Company logo
LLY Eli Lilly and Company
6 Feb 2024
-
2.25
Eli Lilly and Company logo
LLY Eli Lilly and Company
2 Nov 2023
-
-
Eli Lilly and Company logo
LLY Eli Lilly and Company
25 Oct 2016
-
0.66
Eli Lilly and Company logo
LLY Eli Lilly and Company
26 Jul 2016
-
0.62
Eli Lilly and Company logo
LLY Eli Lilly and Company
26 Apr 2016
-
0.38

LLY Earnings Reports FAQ

What is the earnings per share (EPS) for LLY?

The current EPS is 6.64.

What is the company's earnings growth rate?

Over the past 10 years, the earnings growth rate has been approximately 34.24%, reflecting the LLY's performance and XETRA market conditions.

When is the next earnings release date?

Eli Lilly and Company has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Eli Lilly and Company are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for LLY at this time, as Eli Lilly and Company has no recent EPS data to calculate it.